Recombinant multi-species AP2A2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine AP2A2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a subunit of the AP-2 adaptor protein complex, which is involved in linking lipid and protein membrane components with the clathrin lattice. This interaction supports the formation of clathrin-coated vesicles, and the encoded subunit aids in the process by binding polyphosphoinositide-containing lipids in the cell membrane. [provided by RefSeq, Nov 2016]
The Alternative Names of target: 100 kDa coated vesicle protein C,2410074K14Rik,ADTAB,AP-2 complex subunit alpha-2,AP2A2,Adaptor protein complex AP-2 subunit alpha-2,Adaptor-related protein complex 2 subunit alpha-2,Adtab,Alpha-adaptin C,Alpha2-adaptin,Ap2a2,CLAPA2,Clathrin assembly protein complex 2 alpha-C large chain,HIP-9,HIP9,HYPJ,Huntingtin yeast partner J,Huntingtin-interacting protein 9 (HIP-9),Huntingtin-interacting protein J,L25,Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit

Target products collectionGo to AP2A2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP6029-Ag-1/ GM-Tg-hg-IP6029-Ag-2 Human AP2A2 protein Human
GM-Tg-rg-IP6029-Ag-1/ GM-Tg-rg-IP6029-Ag-2 Rat AP2A2 protein Rat
GM-Tg-mg-IP6029-Ag-1/ GM-Tg-mg-IP6029-Ag-2 Mouse AP2A2 protein Mouse
GM-Tg-cynog-IP6029-Ag-1/ GM-Tg-cynog-IP6029-Ag-2 Cynomolgus/Rhesus macaque AP2A2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP6029-Ag-1/ GM-Tg-felg-IP6029-Ag-2 Feline AP2A2 protein Feline
GM-Tg-cang-IP6029-Ag-1/ GM-Tg-cang-IP6029-Ag-2 Canine AP2A2 protein Canine
GM-Tg-bovg-IP6029-Ag-1/ GM-Tg-bovg-IP6029-Ag-2 Bovine AP2A2 protein Bovine
GM-Tg-equg-IP6029-Ag-1/ GM-Tg-equg-IP6029-Ag-2 Equine AP2A2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP6029-Ag-1/ GM-Tg-hg-IP6029-Ag-2; GM-Tg-rg-IP6029-Ag-1/ GM-Tg-rg-IP6029-Ag-2;
GM-Tg-mg-IP6029-Ag-1/ GM-Tg-mg-IP6029-Ag-2; GM-Tg-cynog-IP6029-Ag-1/ GM-Tg-cynog-IP6029-Ag-2;
GM-Tg-felg-IP6029-Ag-1/ GM-Tg-felg-IP6029-Ag-2; GM-Tg-cang-IP6029-Ag-1/ GM-Tg-cang-IP6029-Ag-2;
GM-Tg-bovg-IP6029-Ag-1/ GM-Tg-bovg-IP6029-Ag-2; GM-Tg-equg-IP6029-Ag-1/ GM-Tg-equg-IP6029-Ag-2
Products Name AP2A2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name AP2A2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine AP2A2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.